Drug Shortage Report for CASPOFUNGIN FOR INJECTION
Report ID | 148860 |
Drug Identification Number | 02486989 |
Brand name | CASPOFUNGIN FOR INJECTION |
Common or Proper name | Caspofungin for Injection 50 mg Vial 10 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CASPOFUNGIN |
Strength(s) | 50MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL |
ATC code | J02AX |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-01 |
Estimated end date | 2022-06-30 |
Actual end date | 2022-06-30 |
Shortage status | Resolved |
Updated date | 2022-07-07 |
Company comments | Effective May 2, 2022 this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-11-04 | English | Compare |
v2 | 2021-11-04 | French | Compare |
v3 | 2021-12-24 | English | Compare |
v4 | 2021-12-24 | French | Compare |
v5 | 2022-01-02 | English | Compare |
v6 | 2022-02-28 | English | Compare |
v7 | 2022-02-28 | French | Compare |
v8 | 2022-05-02 | English | Compare |
v9 | 2022-05-02 | French | Compare |
v10 | 2022-07-07 | English | Compare |
v11 | 2022-07-07 | French | Compare |
Showing 1 to 11 of 11